on EnVVeno Medical Corporation (NASDAQ:NVNO)
EnVVeno Medical to Present at Webull Financial Webinar Series
enVVeno Medical Corporation, based in Irvine, California, is set to present at the Webull Financial Corporate Connect Webinar Series focused on Biotech/MedTech. Scheduled for August 21, 2025, at 2:00 PM ET, the presentation will feature Robert Berman, the company's CEO. enVVeno is recognized for its innovative treatment solutions for deep venous disease.
The company's lead product, VenoValve®, is a surgical replacement venous valve, currently undergoing clinical trials. Another product in development, enVVe®, is a non-surgical transcatheter venous valve. Both aim to aid blood circulation in patients with Deep Venous Insufficiency (DVI).
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all EnVVeno Medical Corporation news